Home Biosimilar Antibodies Others Others antibody Rovalpituzumab (Anti-DLL3) For research use only.
Not for use in humans.

Rovalpituzumab (Anti-DLL3)

Synonyms: null

Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.

Rovalpituzumab (Anti-DLL3)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 7.76mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.

Product Details

CAS No. 1613313-01-1
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) supplier | purchase Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) cost | Rovalpituzumab (Anti-DLL3) manufacturer | order Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) distributor